Evidence map›Paper›PMID 39737435›Full record

ArticleFrontiers in neuroscience2024

Adolescent circadian rhythm disruption increases reward and risk-taking.

Lauren M DePoy, Chelsea A Vadnie, Kaitlyn A Petersen, Madeline R Scott, Wei Zong, RuoFei Yin, Ross C Matthaei, Fernanda Juarez Anaya, Callie I Kampe, George C Tseng and 1 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Light therapy in medicine: where do we stand?Annals of translational medicine · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lauren M DePoy *Department of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Chelsea A Vadnie *Department of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Kaitlyn A PetersenDepartment of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Madeline R ScottDepartment of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Wei ZongDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, PA, United States.
RuoFei YinDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, PA, United States.
Ross C MatthaeiDepartment of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Fernanda Juarez AnayaCenter for Neuroscience, University of Pittsburgh, Pittsburgh, PA, United States.
Callie I KampeDavid O. Robbins Neuroscience Program, Department of Psychology, Ohio Wesleyan University, Delaware, OH, United States.
George C TsengDepartment of Biostatistics, University of Pittsburgh, Pittsburgh, PA, United States.
Colleen A McClungDepartment of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.

Funding

Project 5: Circadian RhythmsP50DA039841 · NIDA · JACKSON LABORATORY · PI LAURA G REINHOLDT · 2016 to 2026
$26.2M
Subject Management and BiobankingP50DA046346 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Daniel J. Buysse, Colleen A McClung · 2020 to 2026
$23.4M
Translational Research Training in Sleep MedicineT32HL082610 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Daniel J. Buysse, PETER L FRANZEN · 2007 to 2026
$5.8M
Identification of molecular rhythm changes in postmortem tissue from individuals with psychiatric illness. R01MH111601 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Colleen A McClung, Marianne L Seney · 2018 to 2026
$5.5M
Role of NPAS2 in the nucleus accumbens in drug addictionR01DA039865 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCCLUNG, COLLEEN A · 2015 to 2024
$3.9M
Selective HDAC inhibition and therapeutic target genes: Identification of novel treatments for Bipolar DisorderR01MH106460 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCCLUNG, COLLEEN A · 2016 to 2024
$3.6M
Generating novel mouse tools to investigate brain region and cell-type specific circadian molecular mechanisms of reward and motivationR33DA041872 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOGAN, RYAN W, MCCLUNG, COLLEEN A · 2018 to 2020
$1.1M
Consequences of HDAC2 inhibition in VTA-NAc circuitryRF1MH106460 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCCLUNG, COLLEEN A · 2025 to 2025
$1.0M
Use of in vivo calcium imaging to study addiction.K02DA042886 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MCCLUNG, COLLEEN A · 2017 to 2021
$602k
High-Throughput Computing for Genomics and Bioinformatics ResearchS10OD028483 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEE, ADRIAN V · 2021 to 2021
$574k
Investigating the long-term effects of prenatal circadian rhythm disruption on substance use-related disordersR00DA055064 · NIDA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI Lauren Marie DePoy · 2025 to 2026
$497k
Generating novel mouse tools to investigate brain region and cell-type specific circadian molecular mechanisms of reward and motivationR21DA041872 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LOGAN, RYAN W, MCCLUNG, COLLEEN A · 2016 to 2017
$379k
NHLBI NIH HHS T32 HL082610NIDA NIH HHS F32 DA046117NIDA NIH HHS K02 DA042886NIDA NIH HHS K99 DA055064NIDA NIH HHS L60 DA054665NIDA NIH HHS P50 DA039841NIDA NIH HHS P50 DA046346NIDA NIH HHS R00 DA055064NIDA NIH HHS R01 DA039865NIDA NIH HHS R21 DA041872NIDA NIH HHS R33 DA041872NIH HHS S10 OD028483NIMH NIH HHS R01 MH106460NIMH NIH HHS R01 MH111601NIMH NIH HHS RF1 MH106460
6 · The paper itself

Abstract

Introduction: Circadian rhythm disturbances have long been associated with the development of psychiatric disorders, including mood and substance use disorders. Adolescence is a particularly vulnerable time for the onset of psychiatric disorders and for circadian rhythm and sleep disruptions. Preclinical studies have found that circadian rhythm disruption (CRD) impacts the brain and behavior, but this research is largely focused on adult disruptions. Here, we hypothesized that adolescent CRD would have a greater effect on psychiatric-related behaviors, relative to adult disruption. Methods: We determined the long-term behavioral and neurobiological effects of CRD during early adolescence by exposing mice to 12 h shifts in the light/dark cycle. Adult mice were exposed to the same CRD paradigm. Behavior testing began approximately 4 weeks later for both groups. To identify possible mechanisms, we also measured gene expression in brain regions relevant to circadian rhythms, mood and reward. Results: CRD during early adolescence, but not adulthood, persistently increased exploratory drive (risk-taking behavior) and cocaine preference when tested later in life. Interestingly, we found sex differences when intravenous cocaine self-administration was tested. While female mice with a history of adolescent CRD had a greater propensity to self-administer cocaine, as well as increased motivation and cue-induced reinstatement, male adolescent CRD mice had reduced motivation and extinction responding. Importantly, we found that transcripts in the SCN were affected by adolescent CRD and these were largely distinct across sex. Conclusion: Overall, adolescent CRD in mice caused persistent increases in risky behavior, cocaine reward and cocaine self-administration, which suggests that CRD during adolescence may predispose individuals toward substance use disorders. Future research is required to elucidate how adolescent CRD affects behaviors relevant to mood-and substance use-related disorders across the 24-h day, as well as to identify intervention strategies to alleviate disruption during adolescence and novel therapeutic approaches once symptoms have begun.

Indexed as

adolescenceanxietycircadian disruptioncocainerewardrisk-taking

Identifiers

PMID39737435
PMCPMC11683121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.